PL2687524T3 - Pochodna azolu - Google Patents

Pochodna azolu

Info

Publication number
PL2687524T3
PL2687524T3 PL12757646T PL12757646T PL2687524T3 PL 2687524 T3 PL2687524 T3 PL 2687524T3 PL 12757646 T PL12757646 T PL 12757646T PL 12757646 T PL12757646 T PL 12757646T PL 2687524 T3 PL2687524 T3 PL 2687524T3
Authority
PL
Poland
Prior art keywords
azole derivative
azole
derivative
Prior art date
Application number
PL12757646T
Other languages
English (en)
Inventor
Naoya Ono
Shoichi Kuroda
Yoshihisa Shirasaki
Tetsuo Takayama
Yoshinori Sekiguchi
Fumihito Ushiyama
Yusuke Oka
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of PL2687524T3 publication Critical patent/PL2687524T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
PL12757646T 2011-03-15 2012-03-15 Pochodna azolu PL2687524T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011056149 2011-03-15
PCT/JP2012/056624 WO2012124750A1 (ja) 2011-03-15 2012-03-15 アゾール誘導体
EP12757646.0A EP2687524B1 (en) 2011-03-15 2012-03-15 Azole derivative

Publications (1)

Publication Number Publication Date
PL2687524T3 true PL2687524T3 (pl) 2016-03-31

Family

ID=46830815

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12757646T PL2687524T3 (pl) 2011-03-15 2012-03-15 Pochodna azolu

Country Status (28)

Country Link
US (1) US9181229B2 (pl)
EP (1) EP2687524B1 (pl)
JP (1) JP5828339B2 (pl)
KR (1) KR101854949B1 (pl)
CN (1) CN103502240B (pl)
AU (1) AU2012229834B2 (pl)
BR (1) BR112013022710A2 (pl)
CA (1) CA2829746C (pl)
CY (1) CY1117011T1 (pl)
DK (1) DK2687524T3 (pl)
ES (1) ES2549559T3 (pl)
HR (1) HRP20151062T1 (pl)
HU (1) HUE027055T2 (pl)
IL (1) IL228319A (pl)
ME (1) ME02299B (pl)
MX (1) MX345264B (pl)
MY (1) MY162945A (pl)
PH (1) PH12013501897A1 (pl)
PL (1) PL2687524T3 (pl)
PT (1) PT2687524E (pl)
RS (1) RS54377B1 (pl)
RU (1) RU2573634C2 (pl)
SG (1) SG193461A1 (pl)
SI (1) SI2687524T1 (pl)
SM (1) SMT201500319B (pl)
TW (1) TWI534142B (pl)
WO (1) WO2012124750A1 (pl)
ZA (1) ZA201307179B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6020396B2 (ja) * 2012-09-12 2016-11-02 大正製薬株式会社 アゾール誘導体を含有する医薬
AU2016224536A1 (en) * 2015-02-25 2017-09-07 Taisho Pharmaceutical Co., Ltd. Hair growth composition for cutaneous application
JP2017078044A (ja) * 2015-10-21 2017-04-27 大正製薬株式会社 発毛剤組成物
US11091447B2 (en) 2020-01-03 2021-08-17 Berg Llc UBE2K modulators and methods for their use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0159766B1 (ko) 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
AU1995792A (en) 1991-05-09 1992-12-21 Vertex Pharmaceuticals Incorporated Novel immunosuppressive compounds
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
GB9804426D0 (en) 1998-03-02 1998-04-29 Pfizer Ltd Heterocycles
CA2333997A1 (en) 1998-06-02 1999-12-09 Bristol-Myers Squibb Company Neurotrophic difluoroamide agents
AU1708099A (en) * 1998-06-03 1999-12-20 Amgen, Inc. N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
ATE359267T1 (de) * 1998-06-03 2007-05-15 Guilford Pharm Inc Azaheterozyklischederivate zur behandlung von haarausfall und neurologischer krankheiten
GB9815696D0 (en) 1998-07-20 1998-09-16 Pfizer Ltd Heterocyclics
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
CN1382140A (zh) * 1999-07-09 2002-11-27 奥索-麦克尼尔药品公司 具有神经营养活性的吡咯烷和哌啶、以及含有它们的相关组合物
JP2001247569A (ja) * 1999-08-12 2001-09-11 Japan Tobacco Inc ピロリジン誘導体又はピペリジン誘導体及びその医薬用途
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
JP4221989B2 (ja) 2002-09-30 2009-02-12 大正製薬株式会社 オキサジアゾール誘導体
JP4240978B2 (ja) 2002-09-30 2009-03-18 大正製薬株式会社 アリールオキシメチルオキサジアゾール誘導体
RU2457826C2 (ru) * 2006-12-20 2012-08-10 Тайсо Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое средство от алопеции

Also Published As

Publication number Publication date
IL228319A (en) 2016-11-30
JPWO2012124750A1 (ja) 2014-07-24
HRP20151062T1 (hr) 2015-11-06
ME02299B (me) 2016-02-20
EP2687524B1 (en) 2015-09-30
PH12013501897A1 (en) 2016-02-17
CY1117011T1 (el) 2017-04-05
ES2549559T3 (es) 2015-10-29
MX2013010570A (es) 2013-10-28
CA2829746A1 (en) 2012-09-20
KR20140014171A (ko) 2014-02-05
RU2573634C2 (ru) 2016-01-27
HUE027055T2 (en) 2016-08-29
TW201249833A (en) 2012-12-16
MY162945A (en) 2017-07-31
CN103502240B (zh) 2016-08-31
AU2012229834B2 (en) 2016-04-14
CN103502240A (zh) 2014-01-08
PT2687524E (pt) 2015-12-24
SMT201500319B (it) 2016-02-25
TWI534142B (zh) 2016-05-21
DK2687524T3 (en) 2015-11-09
SG193461A1 (en) 2013-10-30
RU2013145886A (ru) 2015-04-20
RS54377B1 (sr) 2016-04-28
BR112013022710A2 (pt) 2016-12-06
NZ615210A (en) 2014-12-24
HK1189580A1 (zh) 2014-06-13
CA2829746C (en) 2018-10-09
AU2012229834A1 (en) 2013-10-17
US9181229B2 (en) 2015-11-10
MX345264B (es) 2017-01-20
ZA201307179B (en) 2014-12-23
US20130345419A1 (en) 2013-12-26
EP2687524A1 (en) 2014-01-22
KR101854949B1 (ko) 2018-05-04
WO2012124750A1 (ja) 2012-09-20
SI2687524T1 (sl) 2015-11-30
EP2687524A4 (en) 2014-08-20
JP5828339B2 (ja) 2015-12-02

Similar Documents

Publication Publication Date Title
HUE038714T2 (hu) Dispiropirrolidin származék
CO6862160A2 (es) Indazoles
PT2720563T (pt) Resumo
CO6890099A2 (es) Nuevos derivados dihidroquinolina-2-ona
EP2772482A4 (en) azole derivative
LT2751083T (lt) Kvinolono junginys
PT2543357T (pt) Resumo
DE102011100082A8 (de) Traygreifvorrichtung
PL2663506T3 (pl) Zamknięcie
CO6801764A2 (es) Derivados de pirazol
BR112014000879A2 (pt) deflegmador
CO6960543A2 (es) 2-tiopirimidinonas
PT2661870T (pt) Resumo
BR112013028029A2 (pt) composto
CO6960557A2 (es) Derivados de 2-yodo-imidazol
FI20116167L (fi) Järjestely
PL2762466T3 (pl) Pochodna fenylu
DE112011104936A5 (de) Stanzstauchniet
DE112012000958A5 (de) Handsäge
PT2665720E (pt) Derivados de 2-metoxi-piridin-4-ilo
PL2687524T3 (pl) Pochodna azolu
BR112014015607A2 (pt) composto
BR112013032866A2 (pt) composto
DK2476953T3 (da) Fluidbedkedel
DE112012002458A5 (de) Hydrotransformator